Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07034352 · ClinicalTrials.gov registry record · NA
Health Impact 360: Advancing Physical, Social, and Mental Health Among Marginalized Communities for Cardiovascular Health Equity
A NA study of Cardiovascular Health and Health Promotion, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 328
- Enrollment target
- 3
- Study locations
NCT07034352: Active NA study of Cardiovascular Health and Health Promotion, sponsored by University of Michigan.
NCT07034352 is a NA study of Cardiovascular Health and Health Promotion that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 328 participants, below the 154,428-participant average among 13 other Cardiovascular Health trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07034352, a NA study of Cardiovascular Health and Health Promotion, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 328 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this clinical trial is to evaluate an evidence-based intervention, Health Impact 360, toward the promotion of cardiovascular health (CVH), including physical, mental, and social health outcomes, among adults living in marginalized communities. Study hypotheses include: * Participants in the Health Impact 360 intervention arm will have better CVH (i.e., a higher overall LE8 score) at the 16-week endpoint compared to the control. * Participants in the Health Impact 360 intervention arm will report better mental health (i.e., a lower perceived stress score) at the 16-week endpoint compared to the control. * Participants in the Health Impact 360 intervention arm will report better social support and well-being (i.e., higher emotional support and instrumental support scores and reduced social isolation) at the 16-week endpoint compared to control. * Participants with greater intervention engagement (e.g., better session attendance) will experience greater intervention impacts across all primary and secondary outcomes relative to the minimally engaged peers. Researchers will compare outcomes among intervention participants to outcomes among delayed intervention control participants who will be invited to participate in Health Impact 360 once all endpoint measures are collected. Participants will: * Engage in group-based programming twice per week for 8 weeks * Engage in group-based programming once per week for 8 weeks * Participate in survey-based and biometric data collection at two timepoints: baseline and 16-week endpoint * Self-monitor their physical activity via a study-provided pedometer
Primary Outcome
LE8 CVH Score will be averaged for each participant at baseline and 16 weeks on the individual LE8 metrics (i.e., scores of 0-100 for eight items). An average score of 0 to 49 is defined as low CVH, 50 to 79 is moderate CVH, and 80 to 100 is high CVH.
Conditions Studied
Interventions
- BEHAVIORAL Health Impact 360
- OTHER Usual care - Wait list control
Study Locations (3)
Michigan
- Community Health and Social Service Centers (CHASS) - Detroit
- Eastside Community Network (ECN) - Detroit
- Detroit Hispanic Development Corporation (DHDC) - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2025-06-20 |
| Est. Completion | 2026-11 |
| Phase | NA |
What the registry record for NCT07034352 still lists
NCT07034352 is an interventional study that assigns participants to a tested intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap, below the 154,428-participant average among 13 other Cardiovascular Health trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Cardiovascular Health appearing as the primary indexed condition, and to 2 interventions - of which Health Impact 360 is the first listed.
NCT07034352 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07034352 about?
NCT07034352 is a clinical study titled "Health Impact 360: Advancing Physical, Social, and Mental Health Among Marginalized Communities for Cardiovascular Health Equity". The purpose of this clinical trial is to evaluate an evidence-based intervention, Health Impact 360, toward the promotion of cardiovascular health (CVH), including physical, mental, and social health outcomes, among adults living in marginalized communities. Study hypotheses include: * Participant...
What is the current status of trial NCT07034352?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 328 participants. The study started on 2025-06-20. Estimated completion is 2026-11.
What conditions does trial NCT07034352 study?
This clinical trial studies the following conditions: Cardiovascular Health, Health Promotion.
What interventions are being tested in trial NCT07034352?
The interventions under investigation include: Health Impact 360 (BEHAVIORAL), Usual care - Wait list control (OTHER).
Who is sponsoring clinical trial NCT07034352?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07034352 being conducted?
This trial has 3 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07034352's enrollment target sits among peer trials
328 4th of 13 higher than 10 of 13 other Cardiovascular Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Interpersonal Relationships Intervention and Cardiovascular Health
RECRUITING · NA
-
Cardiovascular Effects of Grieving
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
The Potassium Supplementation Study
RECRUITING · NA
-
Early Intervention to Promote Cardiovascular Health of Mothers and Children
RECRUITING · NA
-
Aerobic Exercise: A Potential Rescue From the Negative Ramifications of Poor Sleep
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
- NCT05548413 · 328 participants · NA
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
- NCT06393725 · 328 participants · NA
Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI